Ergoteles LLC Y M Abs Therapeutics, Inc. Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.0 - $15.17 $575,607 - $2.91 Million	191,869 New	191,869 $936,000
Q2 2022 Aug 12, 2022	BUY	$8.22 - $15.13 $46,311 - $85,242	5,634 Added 24.43%	28,697 $434,000
Q1 2022 May 13, 2022	BUY	$6.55 - $17.42 $29,455 - $78,337	4,497 Added 24.22%	23,063 $274,000
Q4 2021 Feb 14, 2022	BUY	$15.51 - $29.31 $287,958 - $544,169	18,566 New	18,566 $301,000
Q4 2020 Feb 11, 2021	SELL	$37.86 - $54.26 $197,780 - $283,454	-5,224 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$35.13 - $43.62 $183,519 - $227,870	5,224 New	5,224 $201,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.